Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
21.7%
% of IDNA's 51 holdings also in GNOM
26.3%
% of GNOM's 39 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 4.1% | 5.0% | 4.1% |
 |
MODERNA, INC. | 3.0% | 2.7% | 2.7% |
|
VIR BIOTECHNOLOGY, INC. | 0.9% | 1.4% | 0.9% |
|
VERVE THERAPEUTICS, INC. | 0.5% | 0.8% | 0.5% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.4% | 0.7% | 0.4% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to GNOM
 |
BEIGENE, LTD. | 5.9% |
 |
SANOFI-AVENTIS | 5.5% |
 |
GSK PLC | 5.4% |
 |
ROCHE HOLDING LTD | 5.4% |
|
EXELIXIS INC | 5.3% |
|
ASTRAZENECA PLC | 5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 5.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | 4.8% |
 |
GENMAB A/S | 4.7% |
|
REVOLUTION MEDICINES, INC. | 4.1% |
IDNA Underweight Relative to GNOM
|
NATERA INC | -6.9% |
|
VERACYTE INC | -4.9% |
|
BIOMARIN PHARMACEUTICAL INC | -4.7% |
|
ALNYLAM PHARMACEUTICALS INC | -4.6% |
|
AGILENT TECHNOLOGIES INC | -4.3% |
|
CRISPR THERAPEUTICS AG | -4.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -4.0% |
|
BIO-TECHNE CORPORATION | -3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.8% |